Defining the landscape of circRNAs in non-small cell lung cancer and their potential as liquid biopsy biomarkers: a complete review including current methods
2021

Circular RNAs in Non-Small Cell Lung Cancer: Potential Biomarkers

publication Evidence: moderate

Author Information

Author(s): Pedraz-Valdunciel Carlos, Rosell Rafael

Primary Institution: Germans Trias i Pujol Research Institute and Hospital

Hypothesis

Can circular RNAs serve as effective biomarkers for early detection and treatment response in non-small cell lung cancer?

Conclusion

Circular RNAs have significant potential as biomarkers for early detection and monitoring of treatment response in non-small cell lung cancer.

Supporting Evidence

  • Circular RNAs are stable and can be found in blood, making them good candidates for biomarkers.
  • Studies show that circular RNAs can help detect lung cancer and monitor treatment responses.
  • Research indicates that circular RNAs are involved in cancer progression and treatment resistance.

Takeaway

Scientists are studying special types of RNA called circular RNAs to see if they can help find lung cancer early and understand how well treatments are working.

Methodology

This review analyzes the biology and current research on circular RNAs in non-small cell lung cancer, focusing on their potential as biomarkers and the methodologies used to study them.

Limitations

Current research is primarily focused on expression analysis in tumor samples, with limited validation in liquid biopsy specimens.

Digital Object Identifier (DOI)

10.20517/evcna.2020.07

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication